Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?

被引：0

作者：

N A Do Thi

P Saillour

L Ferrero

T Paunio

J Mallet

机构：

[1] Laboratoire de Genetique Moleculaire de la Neurotransmission et des Processus Neurodegeneratifs,Department of Molecular Medicine

[2] CNRS,undefined

[3] UMR 7091,undefined

[4] Bat. CERVI,undefined

[5] Hopital Pitie-Salpetriere,undefined

[6] Gencell SAS,undefined

[7] Vitry sur Seine,undefined

[8] Biomedicum,undefined

来源：

Gene Therapy | 2007年 / 14卷

关键词：

adenoviral vector; Parkinson's disease; Glial cell line-derived neurotrophic factor; NSE promoter;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The transfer of the Glial cell line-derived neurotrophic factor (GDNF) gene to the central nervous system by a recombinant adenoviral vector (Ad) was studied. We constructed the adenovirus vector Ad-NSE-GDNF from which the E1, E3/E4 regions of Ad5 have been deleted and in which the GDNF gene was under the control of a neuron-specific enolase (NSE) promoter. The vector was injected into the striatum of a rat model of Parkinson's disease. We found that (i) the NSE promoter can restrict transgene expression in neurons; (ii) Ad-NSE-GDNF significantly protected dopaminergic (DA) neurons in the substantia nigra (SN) but did not reverse the impairments of amphetamine-induced rotational behavior in lesioned rats.

引用

页码：441 / 450

页数：9

共 50 条

[31] The effect of gastrodin on the expression of TNF-α and GDNF in the rat of Parkinson's disease
Yuan, H.
Liu, P.
Xu, J. Y.
Zheng, C. X.
Xu, G. L.
Liang, L. W.
Zhang, S. F.
Wang, M. K.
Li, C. L.
Bai, L. M.
JOURNAL OF NEUROCHEMISTRY, 2009, 109 : 302 - 302
[32] Do Microglial Glucocorticoid Receptors Protect Against Loss of Dopaminergic Neurons in Parkinson's Disease?
Barnum, Christopher
Tansey, Malu G.
MOVEMENT DISORDERS, 2011, 26 (07) : 1196 - 1196
[33] BMP5/7 protect dopaminergic neurons in an alpha-synuclein mouse model of Parkinson's disease
Vitic, Zagorka
Safory, Hazem
Jovanovic, Vukasin M.
Sarusi, Yael
Stavsky, Alexandra
Kahn, Joy
Kuzmina, Alona
Toker, Lilah
Gitler, Daniel
Taube, Ran
Friedel, Roland H.
Engelender, Simone
Brodski, Claude
BRAIN, 2021, 144
[34] Neutralization of Nogo-A Promotes Engraftment of Dopaminergic Neurons in a Rat Model of Mild Parkinson's Disease
Seiler, S.
Di Santo, S.
Widmer, H. R.
CELL TRANSPLANTATION, 2016, 25 (04) : 771 - 771
[35] Effects of creatine on dopaminergic neurons in the intrastriatal 6-OHDA rat model of Parkinson's disease
Huber, AW
Krebs, SH
Andres, RH
Schaller, B
Meyer, M
Seiler, RW
Wallimann, T
Schlattner, U
Widmer, HR
CELL TRANSPLANTATION, 2003, 12 (03) : 311 - 311
[36] The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease
Wang, Xiaoxiao
Zhuang, Wenxin
Fu, Wenyu
Wang, Xiaocui
Lv, E.
Li, Fengjie
Zhou, Shuanhu
Rausch, Wolf-Dieter
Wang, Xin
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (06): : 1583 - 1599
[37] Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease
Gouhier, C
Chalon, S
Aubert-Pouessel, A
Venier-Julienne, MC
Jollivet, C
Benoit, JP
Guilloteau, D
SYNAPSE, 2002, 44 (03) : 124 - 131
[38] GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease
Kramer, Edgar R.
Liss, Birgit
FEBS LETTERS, 2015, 589 (24): : 3760 - 3772
[39] Effects of Grafted Dopamine Neurons on the Neuronal Firing Activity and Gene Expression in the Subthalamic Nucleus in a Rat Model of Parkinson's Disease
Rumpel, R.
Alam, M.
Klein, A.
Oezer, M.
Wesemann, M.
Krauss, J. K.
Schwabe, K.
Ratzka, A.
Grothe, C.
CELL TRANSPLANTATION, 2013, 22 (05) : 914 - 914
[40] GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease
Decressac, Mickael
Ulusoy, Ayse
Mattsson, Bengt
Georgievska, Biljana
Romero-Ramos, Marina
Kirik, Deniz
Bjorklund, Anders
BRAIN, 2011, 134 : 2302 - 2311

← 1 2 3 4 5 →